Meeting
2023 ASCO Annual Meeting
The role of private insurance characteristics in the out-of-pocket costs of patients with multiple myeloma.
Authors
Hamlet Gasoyan
Cleveland Clinic, Cleveland, OH
Hamlet Gasoyan , Michael B. Rothberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6641)
DOI
10.1200/JCO.2023.41.16_suppl.6641
Abstract #
6641
Poster Bd #
133
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Patient-derived MicroOrganoSpheres (MOS) and precision clinical decision-making for patients with multiple myeloma.
First Author: Rui Xi
Poster
2023 ASCO Annual Meeting
Identification of genes encoding targets associated with adverse events in multiple myeloma.
First Author: Xuan Xu
Poster
2022 ASCO Annual Meeting
A phase II study of daratumumab with weekly carfilzomib, pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma.
First Author: Andrew J Yee
Poster
2021 ASCO Annual Meeting
Once weekly selinexor, carfilzomib, and dexamethasone (XKd) in carfilzomib nonrefractory multiple myeloma (MM) patients.
First Author: Cristina Gasparetto